The Dallas Heart Study of 2008 practically revolutionized our understanding of genetic factors involved in NAFLD/NASH, pinpointing PNPLA3 rs738409 as being strongly associated with high hepatic fat and inflammation. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.